Johnson & Johnson (Janssen) Vaccine Johnson & Johnson (Janssen) Vaccine

Johnson & Johnson (Janssen) Vaccine

At the direction of the CDC and FDA, we along with other health care providers are pausing the administration of the Johnson & Johnson (Janssen) vaccine out of an abundance of caution. As of April 13, there have been six reported cases of blood clots out of 6.8 million people who have received the vaccine. The current cases were seen in women ages 18-48.

While these serious reactions are extremely rare, we encourage all individuals who received the J&J vaccine to monitor for symptoms for three weeks post vaccination. Symptoms may include: severe headache, visual changes, abdominal pain, leg pain, confusion or shortness of breath. If you experience these symptoms, please call your doctor immediately. In the event of an emergency, dial 911.

St. Luke’s is temporarily transitioning all future appointments to Moderna or Pfizer doses and patients who already received the J&J vaccine are being contacted to self-monitor for symptoms.